Prometheon Pharma is eliminating needle injections with extended-wear, once weekly patches. Its Topicon™ platform technology was created to achieve transdermal delivery of large molecule drugs like insulin. Our convenient products ensure increased compliance and benefit. Applying a lean model, we identify areas of commercial and strategic interest with streamlined regulatory paths and shortened time to market across broad therapeutic landscapes.